PRPO Overview

Corporate Update Call: Precipio, Inc. will host its Q3-2025 corporate update call on November 17, 2025, at 5:00 PM ET, providing updates on its core businesses and allowing for pre-submitted questions from listeners.

Company Overview: Precipio is a healthcare biotechnology company focused on improving cancer diagnostics to reduce misdiagnoses, enhance laboratory workflow, and improve patient outcomes through innovative diagnostic products and services.

Information Access: Investors and the public can access more information about Precipio through its website and social media platforms, where the company shares disclosures, presentations, and other material information.

Forward-Looking Statements: The press release includes forward-looking statements regarding the company's future performance, which are subject to risks and uncertainties, and should not be relied upon as guarantees of future results.

Zacks Analyst Blog Highlights: The Zacks Equity Research team featured stocks including HSBC Holdings, American Express, TotalEnergies, Armanino Foods, and Precipio, providing insights into their performance and market strategies.

HSBC Performance and Challenges: HSBC's shares have outperformed the foreign banking industry, but restructuring efforts and subdued loan demand may temporarily impact revenue growth despite a strong capital position.

American Express Growth Factors: American Express has seen revenue growth driven by new products and travel spending, but rising expenses and loan loss provisions pose risks to its profitability.

Micro-Cap Stocks Insights: Armanino Foods and Precipio have shown significant year-to-date gains, with Armanino focusing on cost control and expansion, while Precipio is experiencing strong revenue growth but faces liquidity challenges.